Stockreport

Is It Too Late To Reassess ImmunityBio (IBRX) After Its 315% Year To Date Surge [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF If you are wondering whether ImmunityBio's current share price still makes sense after a big run, looking closely at what the market is paying for the business can be j [Read more]